1–8 of 8 results for Paul Hahn
Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
Annual Meeting Talks
2022
The Impact of COVID-19 on US and International Retina Specialists, Their Practices, and Their Patients
2021
Updates from the Field
Predicting Long-term Response to Ranibizumab After Three Injections in Patients With Age-Related Macular Degeneration
2020
How Intraoperative OCT Systems May Improve Outcomes
Netan Choudhry, MD, FRCS(C) FASRS
Member Podcasts
The Changing Avastin Landscape
2019
Complications or Are They: Why We Can NEVER Get Enough ReST
Jeffrey S. Heier, MD
Peter K. Kaiser, MD FASRS
Geoffrey G. Emerson, MD, PhD, FASRS
J. Michael Jumper, MD, FASRS
Ehab N. ELRAYES, MD, PhD ,FASRS
Daniel Simhaee, MD
ASSAF DOTAN, MD
Philip J. Ferrone, MD, FASRS
2018
Highlights from the 2018 Preferences and Trends Survey